Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

MMR vaccination rate among U.S. children aged 19-35 months 1994-2017

As of 2017, around 91.5 percent of children in the U.S. aged 19 to 35 months had been vaccinated against measles, mumps and rubella (MMR). The MMR vaccine is widely used around the world and is recommended by the Centers for Disease Control and Prevention (CDC) for adults who don’t have immunity and all children.

Measles

The number of cases of measles in the United States has dropped significantly since the introduction of the MMR vaccination. However, there has been a recent increase in measles cases, due to the growth of the vaccine hesitancy movement. Despite claims from this movement, the MMR vaccine is safe and effective. One dose of the MMR vaccine is around 93 percent effective against measles, while two doses is 97 percent effective.

Mumps

The MMR vaccine has resulted in a similar decrease in the rate of mumps cases in the U.S. One dose of the MMR vaccine is 78 percent effective against mumps, while two doses is 88 percent effective. Although the MMR vaccine is safe and effective, like any medicine it can have side effects. Common side effects include fever, a mild rash and temporary joint pain and stiffness.

Percentage of children aged 19-35 months who are vaccinated against measles, mumps and rubella (MMR) in the U.S. from 1994 to 2017

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

October 2018

Region

United States

Survey time period

1994 to 2017

Special properties

children aged 19-35 months

Supplementary notes

* Figures from before 2013 were taken from an archived table from the same source and can be found here.

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Vaccine-preventable diseases in the U.S."

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.